Pharminent

US FDA issues final guidance on biosimilarity data use

The US FDA has published final guidance on the development and use of clinical pharmacology data for drugmakers to demonstrate biosimilarity. http://www.biopharma-reporter.com/Markets-Regulations/US-FDA-issues-final-guidance-on-biosimilarity-data-use

Filed under: Biosimilar